# Major Recall Alert: Mivacron Injection 0.2%, Nimbex Injection 2mg/mL Recalled Due to Potential Quality Issues Involving Glass Particles
If you or someone you know relies on medications like Mivacron Injection 0.2% or Nimbex Injection 2mg/mL, this is an important safety alert to take note of. Aspen Pharmacare Asia Limited has issued a recall for these products due to **potential quality issues stemming from deficiencies in the manual visual inspection process.** The issue at hand could lead to **undetected glass particles in ampoules,** which poses a significant risk to patient safety.
This recall has been flagged as critical for public health. Here's everything you need to know about it.
## Why This Recall is Important
Contaminated medications can lead to severe health complications, including irritation, blockages, or organ damage depending on where the particles spread in the body. Undetected **glass particles in ampoules** of Mivacron Injection 0.2% and Nimbex Injection 2mg/mL raise immediate safety concerns.
These medications are often used in anesthesia for muscle relaxation during surgeries or intensive medical care. A breach in quality standards compromises their safety and could result in unforeseen adverse reactions, including serious health risks caused by the glass contamination.
To maintain patient safety, Aspen Pharmacare Asia Limited has voluntarily recalled the affected batches, and regulatory authorities are urging the public to stay vigilant.
---
## Details of the Recall
- **Category**: Pharmaceutical product recall (Nigeria)
- **Brand**: Aspen Pharmacare Asia Limited
- **Products Affected**:
- Mivacron Injection 0.2%
- Nimbex Injection 2mg/mL
- **Reason for Recall**: Deficiencies in the manual visual inspection process that could lead to **glass particles remaining undetected in ampoules**.
- **Announced Date**: 31,149
This important recall has been highlighted by Nigeria's National Agency for Food and Drug Administration and Control (**NAFDAC**) in **Public Alert No. 44/2025.** The agency has strongly advised users, healthcare professionals, and distributors to halt the use or sale of these products immediately.
---
## What You Should Do
Here's how you can take action to protect yourself and others:
- **Stop Usage Immediately**: If you have Mivacron Injection 0.2% or Nimbex Injection 2mg/mL at home or in stock, stop using them.
- **Report Adverse Events**: If you or someone you know has experienced unusual side effects from these medications, report them to the nearest NAFDAC office.
- **Report Substandard Medicines**: If you detect what you believe to be substandard or falsified drugs, contact NAFDAC promptly via their E-reporting platforms or the Med-Safety mobile application.
- **Contact Healthcare Providers**: Speak to your doctor or pharmacist for suitable alternatives if you are currently using the recalled products.
Remember, timely reporting could help save lives.
---
## Stay Safe – Get Instant Recall Alerts
Don’t take risks with your health or your loved ones' well-being. Stay informed about medication recalls with real-time updates directly from NAFDAC.
**Download the official Med-Safety app today** to report adverse drug reactions and receive recall notifications instantly. By keeping this app on your phone, you can ensure safety for you and your community.
### Official Source:
For more information, visit the [official NAFDAC Public Alert page here](https://nafdac.gov.ng/public-alert-no-44-2025-recall-of-mivacron-injection-0-2-nimbex-injection-2mg-ml-over-safety-concerns/).
---
Being informed about recalls like this is essential in preventing health hazards. Protect yourself, your family, and others by staying updated and taking immediate action when recalls are announced. Always consult trusted sources like NAFDAC to verify product safety.